查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598452

組織工程市場：按產品、應用和最終用戶分類 - 2025-2030 年全球預測

Tissue Engineering Market by Product (Biomaterials, Equipment, Services), Application (Cardiovascular Applications, Dental & Craniofacial Applications, Drug Testing & Development), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年組織工程市場價值為431.3億美元，預計2024年將達到512.1億美元，複合年成長率為18.82%，到2030年將達到1442.8億美元。

組織工程是一個跨學科領域，利用生物學、工程學和臨床科學的原理來開發受損組織和器官的功能替代品。透過提供傳統移植的替代方案，我們的目標是解決捐贈器官的短缺問題並解決重要的醫療保健挑戰。其範圍包括再生醫學、疾病建模、藥物測試和體外診斷的應用。主要的最終用途領域是醫療保健行業，特別是整形外科、神經病學和心血管治療。市場成長的主要驅動力是慢性病盛行率的上升和老年人口的增加。先進的3D生物列印技術、生物材料研發以及幹細胞研究等創新正在產生重大影響。此外，政府研究支持和研究經費的增加也產生了正面影響。該領域提供了巨大的商機，特別是在個人化醫療和器官再生方面。為了利用這些機會，公司可以專注於開拓細胞應用和開發創新的支架技術。儘管是一個前景廣闊的市場，但它面臨著一些挑戰，包括高昂的開發成本、監管障礙以及圍繞幹細胞使用的倫理問題。複製複雜組織結構的技術限制也帶來了限制。尋求發展的公司應專注於生物製造和創建更複雜的體外組織模型等領域。組織工程市場的本質是高度創新和快速發展，其特點是不斷進行旨在克服當前限制的研究和開發活動。企業必須跟上技術進步和監管變化，建立策略夥伴關係，並投資全面的研發以推動創新。總體而言，該領域潛力巨大，但必須認真克服現有挑戰才能實現永續的商業性成功。

主要市場統計
基準年[2023] 431.3億美元
預測年份 [2024] 512.1億美元
預測年份 [2030] 1442.8億美元
複合年成長率（%） 18.82%

市場動態：揭示快速發展的組織工程市場的關鍵市場洞察

供需的動態交互作用正在改變組織工程市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 組織工程治療不可逆組織損傷的潛在需求
    • 由於腎臟疾病和文明病的增加，需要有效的再生治療
    • 在先進組織工程應用中增加生物來源基奈米顆粒的使用
  • 市場限制因素
    • 缺乏適當的生物材料和技術來捕捉適當的生理結構
  • 市場機會
    • 3D組織工程領域的技術進步
    • 政府對組織工程研究計劃的支持快速增加
  • 市場挑戰
    • 與組織工程相關的嚴格政府法規

波特五力：駕馭組織工程市場的策略工具

波特的五力架構是了解組織工程市場競爭格局的關鍵工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解組織工程市場的外部影響

外部宏觀環境因素在塑造組織工程市場的績效動態方面發揮關鍵作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解組織工程市場的競爭狀況

組織工程市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣組織工程市場供應商的績效評估

FPNV定位矩陣是評估組織工程市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了組織工程市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，組織工程市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 潛在需要組織工程程序來治療不可逆的組織損傷
      • 由於腎臟疾病和文明病的增加，需要有效的再生治療
      • 在先進組織工程應用中增加生物奈米顆粒的使用
    • 抑制因素
      • 缺乏適當的生物材料和技術來捕捉適當的生理結構
    • 機會
      • 3D組織工程領域的技術進步
      • 政府對組織工程研究計劃的支持激增
    • 任務
      • 與組織工程相關的嚴格政府法規
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章組織工程市場：依產品

  • 生物材料
    • 細胞來源
    • 生長因子和生物活性分子
    • 鷹架材料
      • 複合支架材料
      • 奈米支架材料
      • 天然生物支架材料
      • 合成生物分解性高分子支架材料
  • 裝置
    • 反應器
    • 細胞培養室
    • 成像和流式細胞儀
  • 服務

第7章組織工程市場：依應用分類

  • 心血管應用
  • 牙科和顱顏外科應用
  • 藥物測試和開發
  • 整形外科應用
  • 再生醫學
  • 傷口癒合

第8章組織工程市場：依最終使用者分類

  • 學術和政府研究機構
  • 生物技術和製藥公司
  • 合約調查機構

第9章美洲組織工程市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區組織工程市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲組織工程市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 3D BioFibR 推出兩款 CollaFibR 組織工程產品，進入生物列印和 3D 細胞培養市場。
    • Essent Biologics 推出創新的人體天然組織來源的 I 型膠原蛋白
    • BioMed X 與艾伯維 (AbbVie) 擴大免疫學和組織工程領域的研究合作
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Aspect Biosystems Ltd.
  • B. Braun SE
  • Baxter International Inc.
  • Bayer AG
  • Becton, Dickinson and Company
  • Cook Group Incorporated
  • Corning Incorporated
  • CTIBiotech
  • Frequency Therapeutics
  • Gel4Med
  • General Electric Company
  • Humacyte, Inc.
  • Integra LifeSciences Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic PLC
  • Merck KGaA
  • Miromatrix Medical, Inc.
  • Modern Meadow
  • Novartis AG
  • Organogenesis Inc.
  • Organovo Holdings, Inc.
  • Pfizer Inc.
  • Prellis Biologics
  • ReproCell Inc.
  • Smith & Nephew PLC
  • Stryker Corporation
  • Tissue Regeneration Systems Inc.
  • Vericel Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-0315DDADCE14

The Tissue Engineering Market was valued at USD 43.13 billion in 2023, expected to reach USD 51.21 billion in 2024, and is projected to grow at a CAGR of 18.82%, to USD 144.28 billion by 2030.

Tissue engineering is a multidisciplinary field that harnesses principles from biology, engineering, and clinical sciences to develop functional substitutes for damaged tissues and organs. It aims to solve significant healthcare challenges by offering alternatives to traditional transplantations, thereby addressing the shortage of donor organs. The scope includes applications in regenerative medicine, disease modeling, drug testing, and in vitro diagnostics. Key end-use segments are in the healthcare industry, particularly in orthopedics, neurology, and cardiovascular treatments. Market growth is primarily driven by the rising prevalence of chronic diseases and the increasing geriatric population. Technological innovations-such as advanced 3D bioprinting techniques, development of biomaterials, and stem cell research-serve as significant influencers. Furthermore, increasing governmental support and funding for research contribute positively. The field offers substantial opportunities, particularly in personalized medicine and organ regeneration. To capitalize on these opportunities, businesses can focus on pioneering stem cell applications and developing innovative scaffold technologies. Despite its promising prospects, the market faces several challenges, including high development costs, regulatory hurdles, and ethical concerns surrounding stem cell use. Limitations also arise from technological constraints in replicating complex tissue structures. Companies aiming for growth should focus on areas like biofabrication and the creation of more sophisticated in vitro tissue models. The nature of the tissue engineering market is highly innovative and rapidly evolving, characterized by constant research and development activities aimed at overcoming current limitations. Businesses must stay abreast of technological advances and regulatory changes while forging strategic partnerships and investing in comprehensive R&D to drive innovation. Overall, the field holds vast potential, but it requires careful navigation through existing challenges to achieve sustainable commercial success.

KEY MARKET STATISTICS
Base Year [2023] USD 43.13 billion
Estimated Year [2024] USD 51.21 billion
Forecast Year [2030] USD 144.28 billion
CAGR (%) 18.82%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Tissue Engineering Market

The Tissue Engineering Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Potential need for tissue engineering procedures in treating irreversible damage of tissues
    • Need for effective regenerative treatments owing to a rise in kidney and lifestyle related disorders
    • Growing use of biogenic nanoparticles for advanced tissue engineering applications
  • Market Restraints
    • Lack of suitable biomaterials and techniques for capturing appropriate physiological architectures
  • Market Opportunities
    • Technological advancements in the field of 3D tissue engineering
    • Surging government support for tissue engineering research projects
  • Market Challenges
    • Stringent government regulations associated with tissue engineering

Porter's Five Forces: A Strategic Tool for Navigating the Tissue Engineering Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Tissue Engineering Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Tissue Engineering Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Tissue Engineering Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Tissue Engineering Market

A detailed market share analysis in the Tissue Engineering Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Tissue Engineering Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Tissue Engineering Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Tissue Engineering Market

A strategic analysis of the Tissue Engineering Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Tissue Engineering Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aspect Biosystems Ltd., B. Braun SE, Baxter International Inc., Bayer AG, Becton, Dickinson and Company, Cook Group Incorporated, Corning Incorporated, CTIBiotech, Frequency Therapeutics, Gel4Med, General Electric Company, Humacyte, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Medtronic PLC, Merck KGaA, Miromatrix Medical, Inc., Modern Meadow, Novartis AG, Organogenesis Inc., Organovo Holdings, Inc., Pfizer Inc., Prellis Biologics, ReproCell Inc., Smith & Nephew PLC, Stryker Corporation, Tissue Regeneration Systems Inc., Vericel Corporation, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Tissue Engineering Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Biomaterials, Equipment, and Services. The Biomaterials is further studied across Cell Sources, Growth Factors & Bioactive Molecules, and Scaffold Materials. The Scaffold Materials is further studied across Composite Scaffold Materials, Nano-Scaffold Materials, Natural Biological Scaffold Materials, and Synthetic Biodegradable Polymer Scaffold Materials. The Equipment is further studied across Bioreactors, Cell Culture Chambers, and Image & Flow Cytometers.
  • Based on Application, market is studied across Cardiovascular Applications, Dental & Craniofacial Applications, Drug Testing & Development, Orthopedic Applications, Regenerative Medicine, and Wound Healing.
  • Based on End-User, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Potential need for tissue engineering procedures in treating irreversible damage of tissues
      • 5.1.1.2. Need for effective regenerative treatments owing to a rise in kidney and lifestyle related disorders
      • 5.1.1.3. Growing use of biogenic nanoparticles for advanced tissue engineering applications
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of suitable biomaterials and techniques for capturing appropriate physiological architectures
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in the field of 3D tissue engineering
      • 5.1.3.2. Surging government support for tissue engineering research projects
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent government regulations associated with tissue engineering
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Tissue Engineering Market, by Product

  • 6.1. Introduction
  • 6.2. Biomaterials
    • 6.2.1. Cell Sources
    • 6.2.2. Growth Factors & Bioactive Molecules
    • 6.2.3. Scaffold Materials
      • 6.2.3.1. Composite Scaffold Materials
      • 6.2.3.2. Nano-Scaffold Materials
      • 6.2.3.3. Natural Biological Scaffold Materials
      • 6.2.3.4. Synthetic Biodegradable Polymer Scaffold Materials
  • 6.3. Equipment
    • 6.3.1. Bioreactors
    • 6.3.2. Cell Culture Chambers
    • 6.3.3. Image & Flow Cytometers
  • 6.4. Services

7. Tissue Engineering Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiovascular Applications
  • 7.3. Dental & Craniofacial Applications
  • 7.4. Drug Testing & Development
  • 7.5. Orthopedic Applications
  • 7.6. Regenerative Medicine
  • 7.7. Wound Healing

8. Tissue Engineering Market, by End-User

  • 8.1. Introduction
  • 8.2. Academic & Government Research Institutes
  • 8.3. Biotechnology & Pharmaceutical Companies
  • 8.4. Contract Research Organizations

9. Americas Tissue Engineering Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Tissue Engineering Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Tissue Engineering Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. 3D BioFibR Enters the Bioprinting and 3D Cell Culture Market with the Launch of Two CollaFibR Tissue Engineering Products
    • 12.3.2. Essent Biologics Launches Revolutionary Human Native Tissue-Derived Type I Collagen
    • 12.3.3. BioMed X Extends Research Collaboration ith AbbVie On Immunology And Tissue Engineering
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Aspect Biosystems Ltd.
  • 3. B. Braun SE
  • 4. Baxter International Inc.
  • 5. Bayer AG
  • 6. Becton, Dickinson and Company
  • 7. Cook Group Incorporated
  • 8. Corning Incorporated
  • 9. CTIBiotech
  • 10. Frequency Therapeutics
  • 11. Gel4Med
  • 12. General Electric Company
  • 13. Humacyte, Inc.
  • 14. Integra LifeSciences Corporation
  • 15. Johnson & Johnson Services, Inc.
  • 16. Medtronic PLC
  • 17. Merck KGaA
  • 18. Miromatrix Medical, Inc.
  • 19. Modern Meadow
  • 20. Novartis AG
  • 21. Organogenesis Inc.
  • 22. Organovo Holdings, Inc.
  • 23. Pfizer Inc.
  • 24. Prellis Biologics
  • 25. ReproCell Inc.
  • 26. Smith & Nephew PLC
  • 27. Stryker Corporation
  • 28. Tissue Regeneration Systems Inc.
  • 29. Vericel Corporation
  • 30. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. TISSUE ENGINEERING MARKET RESEARCH PROCESS
  • FIGURE 2. TISSUE ENGINEERING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TISSUE ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TISSUE ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TISSUE ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TISSUE ENGINEERING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TISSUE ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TISSUE ENGINEERING MARKET DYNAMICS
  • TABLE 7. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CELL SOURCES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY GROWTH FACTORS & BIOACTIVE MOLECULES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY COMPOSITE SCAFFOLD MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY NANO-SCAFFOLD MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY NATURAL BIOLOGICAL SCAFFOLD MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY SYNTHETIC BIODEGRADABLE POLYMER SCAFFOLD MATERIALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY BIOREACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CELL CULTURE CHAMBERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY IMAGE & FLOW CYTOMETERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CARDIOVASCULAR APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY DENTAL & CRANIOFACIAL APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY DRUG TESTING & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY ORTHOPEDIC APPLICATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY WOUND HEALING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL TISSUE ENGINEERING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 56. CANADA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. MEXICO TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 62. MEXICO TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 63. MEXICO TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 68. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 69. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 70. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES TISSUE ENGINEERING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 73. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 82. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 84. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. CHINA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. CHINA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 88. CHINA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 89. CHINA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 90. CHINA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. CHINA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. INDIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. INDIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 94. INDIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 95. INDIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 96. INDIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. INDIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. INDONESIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. INDONESIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 100. INDONESIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 101. INDONESIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 102. INDONESIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. INDONESIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. JAPAN TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. JAPAN TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 106. JAPAN TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 107. JAPAN TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 108. JAPAN TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. JAPAN TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. MALAYSIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. MALAYSIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 112. MALAYSIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 113. MALAYSIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 114. MALAYSIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. MALAYSIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 118. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 120. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SINGAPORE TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SINGAPORE TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 124. SINGAPORE TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 125. SINGAPORE TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 126. SINGAPORE TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SINGAPORE TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 132. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. TAIWAN TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. TAIWAN TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 136. TAIWAN TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 137. TAIWAN TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 138. TAIWAN TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. TAIWAN TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. THAILAND TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. THAILAND TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 142. THAILAND TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 143. THAILAND TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 144. THAILAND TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. THAILAND TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. VIETNAM TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. VIETNAM TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 148. VIETNAM TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 149. VIETNAM TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 150. VIETNAM TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 151. VIETNAM TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA TISSUE ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 159. DENMARK TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. DENMARK TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 161. DENMARK TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 162. DENMARK TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 163. DENMARK TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. DENMARK TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. EGYPT TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. EGYPT TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 167. EGYPT TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 168. EGYPT TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 169. EGYPT TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. EGYPT TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. FINLAND TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. FINLAND TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 173. FINLAND TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 174. FINLAND TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 175. FINLAND TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 176. FINLAND TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 177. FRANCE TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 178. FRANCE TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 179. FRANCE TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 180. FRANCE TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 181. FRANCE TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. FRANCE TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 183. GERMANY TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. GERMANY TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 185. GERMANY TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 186. GERMANY TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 187. GERMANY TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. GERMANY TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. ISRAEL TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 190. ISRAEL TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 191. ISRAEL TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 192. ISRAEL TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 193. ISRAEL TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. ISRAEL TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. ITALY TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. ITALY TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 197. ITALY TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 198. ITALY TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 199. ITALY TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. ITALY TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 203. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 204. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 206. NETHERLANDS TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. NIGERIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. NIGERIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 209. NIGERIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 210. NIGERIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 211. NIGERIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. NIGERIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 213. NORWAY TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. NORWAY TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 215. NORWAY TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 216. NORWAY TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 217. NORWAY TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. NORWAY TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. POLAND TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 220. POLAND TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 221. POLAND TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 222. POLAND TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 223. POLAND TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. POLAND TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. QATAR TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. QATAR TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 227. QATAR TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 228. QATAR TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 229. QATAR TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. QATAR TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. RUSSIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. RUSSIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 233. RUSSIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 234. RUSSIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 235. RUSSIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 236. RUSSIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 240. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 242. SAUDI ARABIA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 243. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 244. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 245. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 246. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 248. SOUTH AFRICA TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 249. SPAIN TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. SPAIN TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 251. SPAIN TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 252. SPAIN TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 253. SPAIN TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 254. SPAIN TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 255. SWEDEN TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 256. SWEDEN TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 257. SWEDEN TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 258. SWEDEN TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 259. SWEDEN TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 260. SWEDEN TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. SWITZERLAND TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 262. SWITZERLAND TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 263. SWITZERLAND TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 264. SWITZERLAND TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. SWITZERLAND TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 267. TURKEY TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 268. TURKEY TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 269. TURKEY TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 270. TURKEY TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 271. TURKEY TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 272. TURKEY TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 273. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 274. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 275. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 276. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 279. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 280. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, BY BIOMATERIALS, 2018-2030 (USD MILLION)
  • TABLE 281. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, BY SCAFFOLD MATERIALS, 2018-2030 (USD MILLION)
  • TABLE 282. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 284. UNITED KINGDOM TISSUE ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 285. TISSUE ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 286. TISSUE ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023